Factsheet and Information Brochure
Factsheet
Target Market
Costs and charges
Fund rules (136 kB)
Prospectus (1369 kB)
Periodic reports
Sustainability SFDR (924 kB)
Annual review (PF) (2879 kB)
Semi-annual report (PF) (189 kB)
Marketing material
Brief fund information
Summary SFDR (143 kB)
AstraZeneca Allemansfond
Legal name: AstraZeneca Allemansfond
Equity Fund Registered in Sweden (Non-UCITS)
Bid
About risk
Historical yields are not a guarantee of future returns. A fund can both increase and decrease in value and it is not guaranteed that you will recover the entire invested amount. Note that a fund with risk level 5-7, as stated in the fund's fact sheet (KID), can vary greatly in value due to the fund's composition and management methodology. The prospectus, fund rules and KID are available under each fund. Summary of investors' rights.
The fund is actively managed special fund (non-UCITS) and thereby the fund deviates from a UCITS fund by concentrating holdings to a smaller number of equities issued by companies in primarily Sweden. The fund invests a significant amount (maximum of 50% of assets) in AstraZeneca.
The fund is reported as an Article 8 fund pursuant to EU regulation 2019/2088 on sustainability-related disclosures in the financial services sector (SFDR).
The fund is reported as an Article 8 fund pursuant to EU regulation 2019/2088 on sustainability-related disclosures in the financial services sector (SFDR).
Fund manager
Ulrika Orstadius Experience in the fund industry 2011. Portfolio Manager since 1 November 2022.
|
|
||
|---|---|---|---|
|
The risk indicator provides guidance on the risk level for this product relative to other financial products. It shows the likelihood that the product will decrease in value due to market performance. Risk level 1 represents a low risk and risk level 7 is a high risk.
|
|
30.06.2024
|
||
|---|---|---|---|
|
The rating shows which funds have historically posted the strongest performance in relation to risk. Ratings are denoted by a scale of one to five stars, with five as the highest rating. A fund must have a performance history of at least three years to receive a rating.
Read more about the fund's rating |
|
|
||
|---|---|---|---|
|
This fund promotes environmental and social characteristics through its investments but does not have sustainable investments as its objective. As a result, the fund takes into consideration the environment and climate, as well as human rights, employees’ rights and corruption. The fund is reported as an Article 8 fund pursuant to EU regulation on sustainability-related disclosures in the financial services sector (SFDR). |
|
31.05.2024
|
|||
|---|---|---|---|
|
The sustainability rating is developed by the fund information company Morningstar. The rating measures how well the fund's investee companies manage sustainability risks relative to other funds within the same global Morningstar category. If the fund has invested in government bonds issued by sovereign states, the respective country's sustainability risk is included in the calculation. The analyzed funds can receive a sustainability rating between 1 and 5 globes, with 5 as the highest rating. The fund complies with the UN Principles for Responsible Investments. |
Graph
Performance
| Rate 19.07.2024 | 1 week | 1 month | 3 months | 2024 | 1 year | 5 years | 10 years |
|---|---|---|---|---|---|---|---|
| 4,178.61 SEK | - | 2.42% | 9.08% | 18.55% | 23.71% | 122.92% | 307.88% |
Portfolio 11.07.2024
Portfolio manager comments — Q2 2024
Fund performance was positive in Q2 and the fund rose just over 6.5% in SEK. However, returns were weighed down by the holding in the installation company Bravida when an incident of over-billing by one of the company’s businesses was reported and confirmed. We have a close dialogue with management regarding the company’s measures to strengthen internal routines and processes, which will be followed up. The fund was also negatively affected by the holdings in Autoliv and Volvo, which have been weighed down by concerns about a weaker economy.
The holdings with the strongest contribution to returns included AstraZeneca, ABB and Sweco. During the quarter AstraZeneca held a capital market day with positive outlooks. Both ABB and Sweco posted strength when the companies reported stronger than expected results.
The fund increased the holding in Sandvik, which has an attractive exposure to the mining industry and the green transition. We decreased the holdings in Indutrade and Atlas Copco due to relatively high valuations.
In the upcoming reporting period we will continue to focus on investee companies that have sustainable business models and competitive offers with sustainable growth even in a weaker economy.
Portfolio distribution 30.06.2024
Geographic breakdown 30.06.2024
